Relvar Ellipta

Main information

  • Trade name:
  • Relvar Ellipta 100mcg + 25mcg (eq. to 92mcg + 22mcg delivered dose) Dry Powder for Inhalation
  • Dosage:
  • 100mcg + 25mcg (eq. to 92mcg + 22mcg delivered dose)
  • Pharmaceutical form:
  • Dry Powder for Inhalation
  • Units in package:
  • In a box of 1 - sealed foil laminate tray containing 1 light grey body, pale blue mouthpiece cover and dose counter plastic inha
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Glaxo Operations UK LTd

Documents

Localization

  • Available in:
  • Relvar Ellipta 100mcg + 25mcg (eq. to 92mcg + 22mcg delivered dose) Dry Powder for Inhalation
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DR-XY44202
  • Authorization date:
  • 13-02-2020
  • Last update:
  • 26-01-2017